Aedating 4 1 iq
We defined health care access and network using several proxies including insurance status (Private, Medicare, Medicaid or other government insurance, none/unknown), usual source of care (clinic or health center, doctor's office/health maintenance organization, emergency department, other place NOS, no usual place/unknown), and number of visits to health care providers in the past year (0-1, 2-3, 4-9, ), chronic medical conditions (history of arthritis, cancer, cardiovascular disease, diabetes, liver disease, lung disease), and seen by a mental health professional within past year (yes/no), as a proxy for respondents' medical and psychiatric illness burden. To determine predictors of MCUFI use, we performed multivariate logistic regression.
As there were significant missing data for income (n = 2,403) and alcohol intake (n = 4,445) among participants included in the main model (n = 32,328), we performed multiple imputation by chained equations.: age, sex, race/ethnicity, educational level, imputed family income, marital status, insurance status, smoking status, imputed alcohol intake, physical activity level, self-reported health status, chronic medical conditions, having seen a mental health professional in past year, and use of other prescription sedative medication.
” Those reporting prescription medication use were then asked to show all of their medication containers to the interviewer for recording.
If participants could not produce containers, interviewers asked for verbal confirmation of medication name.
few have investigated the current prevalence, patterns, and predictors of use of prescription medications for insomnia.
Our definition included medications that are more often prescribed for treatment of insomnia than for other indications, and was consistent with prior epidemiologic studies examining prescription medication use for insomnia.
We defined MCUFI use as use of any of the following medications in the preceding month: benzodiazepine receptor agonists (eszopiclone, zaleplon, zolpidem, estazolam, flurazepam, quazepam, temazepam, triazolam), barbiturates (amobarbital, amobarbitalsecobarbital, chloral hydrate), doxepin, quetiapine, ramelteon, and trazodone.
We estimated prevalence of MCUFI use and concurrent use of another sedating medication.
Lastly, among the subsample participating in NHANES 2005-2008 (n = 10,878) who were also queried specifically about use of pills or medications “to help with sleep,” we quantified prevalence of use of sleep aids (yes/ no) and explored concurrent use of MCUFIs and sleep aids.
Of note, specific types of medications used to help with sleep were not elicited.
Search for aedating 4 1 iq:
Data on non-prescription medications used for insomnia, as well as reasons for use of prescription medications, were not available.